Design, synthesis and biological evaluation of substituted (+)-SG-1 derivatives as novel anti-HIV agents. 2018

Xiaoyu Liu, and Panpan Chen, and Xiaoyu Li, and Mingyu Ba, and Xiaozhen Jiao, and Ying Guo, and Ping Xie
State Key Laboratory of Bioactive Substance and Function of Natural Medicine, Beijing Key Laboratory of Active Substance Discovery and Druggability Evaluation, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 1 Xiannongtan Street, Beijing 100050, People's Republic of China.

SG-1 was previously identified as a potent Non-nucleoside reverse transcriptase inhibitors (NNRTI) which works through inhibition of reverse transcriptase (RT) RNA-dependent DNA polymerase activity via a direct binding event. To further investigate the relationship between its structure and activity, four series of novel analogues were designed and synthesized with 12 of them inhibiting HIV-1 replication with IC50s in the range 0.09-6.71 μM. Compound 4b, 4c, 4f, 2 and 6b were further tested on two NNRTI-resistant HIV-1 strains and one NNRTI-resistant superbug. The result showed that RT- E138K/M184V mutant virus conferred 4.7-9.1-fold resistance to 4c, 4f, 2 and 6b, but only showed slight resistance to 4b (2-fold) which was better than SG-1.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D005732 Gangliosides A subclass of ACIDIC GLYCOSPHINGOLIPIDS. They contain one or more sialic acid (N-ACETYLNEURAMINIC ACID) residues. Using the Svennerholm system of abbrevations, gangliosides are designated G for ganglioside, plus subscript M, D, or T for mono-, di-, or trisialo, respectively, the subscript letter being followed by a subscript arabic numeral to indicated sequence of migration in thin-layer chromatograms. (From Oxford Dictionary of Biochemistry and Molecular Biology, 1997) Ganglioside,Sialoglycosphingolipids
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D019380 Anti-HIV Agents Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. AIDS Drug,AIDS Drugs,Anti-AIDS Agents,Anti-AIDS Drug,Anti-HIV Agent,Anti-HIV Drug,Anti-AIDS Drugs,Anti-HIV Drugs,Agent, Anti-HIV,Agents, Anti-AIDS,Agents, Anti-HIV,Anti AIDS Agents,Anti AIDS Drug,Anti AIDS Drugs,Anti HIV Agent,Anti HIV Agents,Anti HIV Drug,Anti HIV Drugs,Drug, AIDS,Drug, Anti-AIDS,Drug, Anti-HIV,Drugs, AIDS,Drugs, Anti-AIDS,Drugs, Anti-HIV
D024882 Drug Resistance, Viral The ability of viruses to resist or to become tolerant to chemotherapeutic agents or antiviral agents. This resistance is acquired through gene mutation. Antiviral Drug Resistance,Antiviral Drug Resistances,Drug Resistances, Viral

Related Publications

Xiaoyu Liu, and Panpan Chen, and Xiaoyu Li, and Mingyu Ba, and Xiaozhen Jiao, and Ying Guo, and Ping Xie
September 2015, Chemical biology & drug design,
Xiaoyu Liu, and Panpan Chen, and Xiaoyu Li, and Mingyu Ba, and Xiaozhen Jiao, and Ying Guo, and Ping Xie
January 2023, Current HIV research,
Xiaoyu Liu, and Panpan Chen, and Xiaoyu Li, and Mingyu Ba, and Xiaozhen Jiao, and Ying Guo, and Ping Xie
June 2021, Bioorganic & medicinal chemistry,
Xiaoyu Liu, and Panpan Chen, and Xiaoyu Li, and Mingyu Ba, and Xiaozhen Jiao, and Ying Guo, and Ping Xie
September 2018, Molecules (Basel, Switzerland),
Xiaoyu Liu, and Panpan Chen, and Xiaoyu Li, and Mingyu Ba, and Xiaozhen Jiao, and Ying Guo, and Ping Xie
February 2016, Chemical biology & drug design,
Xiaoyu Liu, and Panpan Chen, and Xiaoyu Li, and Mingyu Ba, and Xiaozhen Jiao, and Ying Guo, and Ping Xie
February 2020, RSC advances,
Xiaoyu Liu, and Panpan Chen, and Xiaoyu Li, and Mingyu Ba, and Xiaozhen Jiao, and Ying Guo, and Ping Xie
January 2016, Anti-cancer agents in medicinal chemistry,
Xiaoyu Liu, and Panpan Chen, and Xiaoyu Li, and Mingyu Ba, and Xiaozhen Jiao, and Ying Guo, and Ping Xie
August 2012, Journal of enzyme inhibition and medicinal chemistry,
Xiaoyu Liu, and Panpan Chen, and Xiaoyu Li, and Mingyu Ba, and Xiaozhen Jiao, and Ying Guo, and Ping Xie
July 2015, Organic & biomolecular chemistry,
Xiaoyu Liu, and Panpan Chen, and Xiaoyu Li, and Mingyu Ba, and Xiaozhen Jiao, and Ying Guo, and Ping Xie
February 2012, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!